RESEARCH & TECHNOLOGY

Research experience. Perspective for ingredient selection.

Knowledge from stem cell conditioned media research and commercialization informs plant-derived materials. Explore development backgrounds and ingredient-specific technical and quality documentation.

RESEARCH HERITAGE

Knowledge from conditioned media research. New directions in plant-derived materials.

Behind these materials is expertise accumulated through stem cell conditioned media research and commercialization. ABio materials carries that knowledge forward and combines it with its own plant research to develop today’s ingredients.

Technology development and documentation: ABio materials. EXOSOME supports ingredient selection and introduction to Japan.

01

STEM CELL CULTIVATION TECHNOLOGY

Celtivation™

ABio materials stem cell culture technology. We review cell origin, culture processes and conditioned media quality for each ingredient and provide corresponding materials and documentation.

Celtivation™ technology illustration
01

01

Adipose tissue sourcing & donor screening

02

02

Isolation of adipose-derived stem cells

03

03

Storage, thawing & large-scale culture

04

04

Production culture using Celtivation™

02

EXOSOME ISOLATION & PURIFICATION

ExoTraction®

ABio materials process technology for isolating and purifying exosomes from plants, lactic acid bacteria and other sources. Manufacturing and quality information is provided for the relevant material and application.

ExoTraction® technology illustration
01

Smart Cultivating System

Plant & lactic acid bacteria culture systems

02

Isolation by Chemical

ATPS (Aqueous Two-Phase System) separation

03

High Purification

Large-scale production of high-purity plant-derived exosomes

PLANT-DERIVED PDRN

Developing plant-derived PDRN ingredients.

Based on ABio materials ingredient documentation, we present botanical origins, manufacturing processes, composition and specifications. Cosmetic ingredients and development for food use are covered separately.

03

HUMAN iPSC-DERIVED MESENCHYMAL STEM CELLS

iPSC-derived MSC

Research and culture technology presented by ABio materials for mesenchymal stem cells differentiated from iPSCs. Ingredient relevance and quality documentation are reviewed individually.

iPSC-derived MSC technology illustration
01

Uniformity

Aiming for more consistent cell quality than conventional MSCs

02

Scalability

Continuous, stable subculture and large-scale production

03

Safety

Review quality evaluations and test documentation for the material

04

Clean Facility

Documentation on the developer’s culture and manufacturing environment

04

MICROFLUIDIC LNP ENCAPSULATION

Cellularsome®

ABio materials encapsulation technology uses plant-derived phospholipids and microfluidic processing. It encapsulates ingredients in lipid bilayers and is presented separately from naturally derived exosomes.

Cellularsome® technology illustration
01

Microfluidic Chip

Microfluidic processing designed for uniform particle formation

02

Plant Phospholipid

Bilayer structure using plant-derived phospholipids

03

LNP Encapsulation

Delivery design for encapsulating bioactive substances

04

Formulation

Product development solutions tailored to the material

TECHNICAL DOCUMENTS

Understand the material’s background. Make informed selections.

We organize information on origin, manufacturing, quality evaluation and test conditions. Assess ingredient studies and formulated-product studies according to their specific subjects and applications.

Technical information is presented using ABio materials public documentation. Contact EXOSOME for adoption requirements and availability.

View source ↗